© 2026 Noah Pharmaceuticals, Inc. All rights reserved.
The active ingredients in Noah Pharmaceuticals' lead product candidate are each approved by the U.S. Food and Drug Administration for other indications. The fixed-dose combination itself is investigational: it has not been approved by the FDA or any other regulatory authority for any use, including the treatment of Alzheimer's disease, and its safety and efficacy for that use have not been established. Nothing on this website constitutes medical advice, and nothing on this website constitutes an offer to sell or a solicitation of an offer to buy any securities.
This website contains forward-looking statements regarding the company's development plans, regulatory strategy, and anticipated milestones. Such statements involve risks and uncertainties; actual events may differ materially. The company undertakes no obligation to update them.